|
Prevalence of malignancy in children who received phototherapy during neonatal period
|
Fatemeh Naghdi *1    , Maryam Ilkhany2 |
1- Assistant Professor, Pediatrician, Department of Pediatrics, School of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran , dr_fatemeh_@yahoo.com
2- Medical Student, Department of Pediatrics, School of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran |
|
|
Abstract: (215 Views) |
Background: Phototherapy is an effective treatment for neonatal hyperbilirubinemia, preventing severe complications such as kernicterus. However, concerns about its potential long-term effects, including an association with cancer in childhood, persist. This study aimed to assess the prevalence of cancer in children with a history of phototherapy during infancy and investigate related risk factors.
Materials and methods: A cross-sectional descriptive study was conducted on 2328 children aged 1 to 14 years who underwent phototherapy during infancy in Tehran Hospitals between 2024 and 2025. Data were collected through interviews with parents and medical record reviews. Variables included demographic information, phototherapy details (age at initiation, duration, number of sessions), and cancer diagnoses. Statistical analyses were done by chi-square tests and ANOVA.
Results: Among the participants, 37 children (1.6%) were diagnosed with cancer, while 2291 (98.4%) had no history of cancer. The most common cancer types were leukemia (12 cases, 0.5%) and neuroblastoma (12 cases, 0.5%), followed by lymphoma (9 cases, 0.4%) and brain tumors (4 cases, 0.2%). A significant association was found between the number of phototherapy sessions and cancer prevalence (p< 0.001); children diagnosed with cancer received a mean of 3.41 phototherapy sessions compared to 1.96 sessions in the non-cancer group. Additionally, the mean age at initiation of phototherapy was significantly lower in the cancer group (2.16 days) compared to the non-cancer group (13.87 days; p< 0.001). No significant associations were observed between cancer prevalence and demographic variables such as gender, parental education, occupation, or place of residence.
Conclusion: The findings suggest that a higher number of phototherapy sessions and earlier initiation of treatment may be associated with an increased risk of certain cancers in children |
|
| Keywords: Phototherapy, Neonatal hyperbilirubinemia, Cancer prevalence |
|
|
Full-Text [PDF 783 kb]
(85 Downloads)
|
Semi-pilot: Survey/Cross Sectional/Descriptive |
Subject:
Pediatric
Received: 2025/09/28 | Accepted: 2026/02/17 | Published: 2026/09/1
|
|
|
|
|
|
|
| References |
1. Wickremasinghe AC, Kuzniewicz MW, McCulloch CE, Newman TB. Efficacy of subthreshold newborn phototherapy during the birth hospitalization in preventing readmission for phototherapy. JAMA Pediatr 2018;172:378-85. [ DOI:10.1001/jamapediatrics.2017.5630] 2. Faulhaber FR, Procianoy RS, Silveira RC. Side effects of phototherapy on neonates. Am J Perinatol 2019;36:252-57. [ DOI:10.1055/s-0038-1667379] 3. Newman TB, Wickremasinghe AC, Walsh EM, Grimes BA, McCulloch CE, Kuzniewicz MW. Retrospective cohort study of phototherapy and childhood cancer in Northern California. Pediatrics 2016;137: e20151354. [ DOI:10.1542/peds.2015-1354] 4. Mitra S, Rennie J. Neonatal jaundice: aetiology, diagnosis and treatment. Br J Hosp Med (Lond) 2017;78:699-704. [ DOI:10.12968/hmed.2017.78.12.699] 5. Greco C, Arnolda G, Boo NY, Iskander IF, Okolo AA, Rohsiswatmo R, et al. Neonatal jaundice in low- and middle-income countries: lessons and future directions from the 2015 Don Ostrow Trieste Yellow Retreat. Neonatology 2016;110:172-80. [ DOI:10.1159/000445708] 6. Zhou S, Wu X, Ma A, Zhang M, Liu Y. Analysis of therapeutic effect of intermittent and continuous phototherapy on neonatal hemolytic jaundice. Exp Ther Med 2019;17:4007-12. [ DOI:10.3892/etm.2019.7432] 7. Deshmukh J, Deshmukh M, Patole S. Probiotics for the management of neonatal hyperbilirubinemia: a systematic review of randomized controlled trials. J Matern Fetal Neonatal Med 2019;32:154-63. [ DOI:10.1080/14767058.2017.1369520] 8. Mojtahedi SY, Izadi A, Seirafi G, Khedmat L, Tavakolizadeh R. Risk factors associated with neonatal jaundice: A cross-sectional study from Iran. Open Access Maced J Med Sci 2018;6:1387-93. [ DOI:10.3889/oamjms.2018.319] 9. Jiao Y, Jin Y, Meng H, Wen M. An analysis on treatment effect of blue light phototherapy combined with Bifico in treating neonatal hemolytic jaundice. Exp Ther Med 2018;16:1360-64. [ DOI:10.3892/etm.2018.6340] 10. Ebbesen F, Hansen TWR, Maisels MJ. Update on phototherapy in jaundiced neonates. Curr Pediatr Rev 2017;13:176-80. [ DOI:10.2174/1573396313666170718150056] 11. Arnold C, Tyson JE, Pedroza C, Carlo WA, Stevenson DK, Wong R, et al. Cycled phototherapy dose-finding study for extremely low-birth-weight infants: a randomized clinical trial. JAMA Pediatr 2020;174:649-56. [ DOI:10.1001/jamapediatrics.2020.0559] 12. Roll EB, Christensen T, Gederaas OA. Effects of bilirubin and phototherapy on osmotic fragility and haematoporphyrin-induced photohaemolysis of normal erythrocytes and spherocytes. Acta Paediatr 2005;94:1443-47. [ DOI:10.1111/j.1651-2227.2005.tb01818.x] 13. El-Abdin MYZ, El-Salam MA, Ibrhim MY, Koraa SSM, Mahmoud E. Phototherapy and DNA changes in full term neonates with hyperbilirubinemia. Egypt J Med Hum Genet 2012;13:29-35. [ DOI:10.1016/j.ejmhg.2011.11.003] 14. Mesbah-Namin SA, Shahidi M, Nakhshab M. An increased genotoxic risk in lymphocytes from phototherapy-treated hyperbilirubinemic neonates. Iran Biomed J 2017;21:182-89. [ DOI:10.18869/acadpub.ibj.21.3.182] 15. Newman TB, Wickremasinghe AC, Walsh EM, Grimes BA, McCulloch CE, Kuzniewicz MW. Retrospective cohort study of phototherapy and childhood cancer in northern California. Pediatrics 2016;137:e20151354. [ DOI:10.1542/peds.2015-1354] 16. Morris BH, Oh W, Tyson JE, Stevenson DK, Phelps DL, O'Shea TM, et al. Aggressive vs conservative phototherapy for infants with extremely low birth weight. N Engl J Med 2008;359):1885-96. 17. Das S, van Landeghem FKH. Clinicopathological spectrum of bilirubin encephalopathy/kernicterus. Diagnostics (Basel) 2019;9:24. [ DOI:10.3390/diagnostics9010024] 18. Alizadeh Taheri P, Sadeghi M, Sajjadian N. Severe neonatal hyperbilirubinemia leading to exchange transfusion. Med J Islam Repub Iran 2014;28:64. 19. Ansong-Assoku B, Ankola PA. Neonatal jaundice. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020. 20. Kalakonda A, Jenkins BA, John S. Physiology, bilirubin. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020.
|
|
| Send email to the article author |
|
|
|
| Add your comments about this article |
|
|
|
|
|
